CSIMarket
 


Marker Therapeutics inc   (MRKR)
Other Ticker:  
 
 

Marker Therapeutics Inc Accounts Receivables Turnover Ratio from the forth quarter 2023 to the forth quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Marker Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 2.68, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Marker Therapeutics Inc 's Average receivable collection period in the Dec 31 2023 quarter, has increased to 136 days, from 64 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 307 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2282, from overall ranking in the third quarter 2023 at 2438.

What is Receivable Turnover Ratio?
What is Marker Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




MRKR Receivables Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Receivable Change -57.21 % -95.04 % 178.21 % 95226.59 % 1013403.8 %
Y / Y Revenue Change - -93.48 % -3.52 % 390.95 % 166.5 %
Receivable Turnover Ratio (TTM) 2.68 5.74 6.45 7.53 7.65
MRKR's Total Ranking # 2282 # 2438 # 2218 # 1810 # 2003
Average receivable collection period 136 64 57 48 48
Seq. Receivable Change 1133.68 % -95.23 % -16.17 % -13.29 % 42.89 %
Seq. Revenue Change - -66.22 % -83.89 % 43.07 % -16.22 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 108
Healthcare Sector # 308
Overall Market # 2282

Receivable Turnover Ratio Statistics
High Average Low
12.02 7.01 2.68
(Sep 30 2022)   (Dec 31 2023)






Financial Statements
Marker Therapeutics Inc 's Accounts Receivable $ 1 Millions Visit MRKR's Balance sheet
Marker Therapeutics Inc 's Sales TTM $ 3 Millions Visit MRKR's Income Statement
Where are MRKR's Sales coming from? Visit MRKR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MRKR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for MRKR's Competitors
Receivables Turnover Ratio for MRKR's Suppliers
Accounts Receivables Turnover Ratio for MRKR's Customers

You may also want to know
MRKR's Growth Rates MRKR's Roa MRKR's Inventory Turnover Ratio MRKR's Dividend Comparisons
MRKR's Profitability Ratios MRKR's Roi MRKR's Asset Turnover Ratio MRKR's Dividend Growth
MRKR's Valuation Ratios MRKR's Roe MRKR's Financial Strength Ratios MRKR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Insmed Inc  8.84 $ 305.528  Millions$ 34.560  Millions
Inspire Medical Systems inc   8.77 $ 624.223  Millions$ 71.153  Millions
Encompass Health Corporation  8.75 $ 4,801.200  Millions$ 548.575  Millions
Igc Pharma Inc   8.66 $ 1.215  Millions$ 0.140  Millions
Adapthealth Corp   8.66 $ 3,200.177  Millions$ 369.646  Millions
Clearpoint Neuro Inc   8.62 $ 23.955  Millions$ 2.778  Millions
Veracyte inc   8.62 $ 361.051  Millions$ 41.882  Millions
Ngm Biopharmaceuticals Inc   8.61 $ 4.417  Millions$ 0.513  Millions
Adma Biologics Inc   8.46 $ 257.942  Millions$ 30.497  Millions
Astrazeneca Plc  8.45 $ 45,811.000  Millions$ 5,424.000  Millions
Inmode Ltd   8.39 $ 492.048  Millions$ 58.630  Millions
Capricor Therapeutics inc   8.38 $ 25.178  Millions$ 3.004  Millions
Insulet Corporation  8.33 $ 1,697.100  Millions$ 203.850  Millions
Ati Physical Therapy Inc   8.31 $ 699.016  Millions$ 84.118  Millions
Cadre Holdings Inc   8.28 $ 481.726  Millions$ 58.172  Millions
Nephros Inc   8.28 $ 13.405  Millions$ 1.620  Millions
Amneal Pharmaceuticals Inc   8.24 $ 2,393.565  Millions$ 290.319  Millions
Prosomnus Inc   8.19 $ 27.652  Millions$ 3.376  Millions
Silk Road Medical Inc   8.16 $ 177.086  Millions$ 21.708  Millions
Alpha Pro Tech Ltd   8.12 $ 60.829  Millions$ 7.488  Millions
Becton Dickinson And Company  8.09 $ 19,492.000  Millions$ 2,410.750  Millions
Ensign Group Inc  8.07 $ 3,729.355  Millions$ 461.842  Millions
Neurometrix Inc   8.06 $ 4.947  Millions$ 0.614  Millions
Idexx Laboratories Inc  8.05 $ 3,659.970  Millions$ 454.507  Millions
Atricure Inc   8.05 $ 398.370  Millions$ 49.513  Millions
Glaukos Corp  8.04 $ 314.136  Millions$ 39.070  Millions
Delcath Systems Inc   8.01 $ 2.065  Millions$ 0.258  Millions
Vaxart Inc   7.92 $ 7.379  Millions$ 0.931  Millions
Dynatronics Corporation  7.89 $ 35.743  Millions$ 4.533  Millions
Akebia Therapeutics Inc   7.84 $ 194.623  Millions$ 24.809  Millions

Date modified: 2024-03-26T21:23:52+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com